SH Symposium: New approaches to STI diagnosis, prevention and control
Wednesday, November 18, 2020 |
10:00 AM - 11:30 AM |
Overview
As the STI epidemic continues to increase, new approaches to diagnosis, prevention and control are urgently needed. This session will focus on emerging strategies, such as vaccines and novel approaches to diagnosis and surveillance.
Speaker
Prof Kate Seib
Research Leader & Deputy Director
Institute for Glycomics, Griffith University
Gonorrhoea vaccines - the road ahead
Biography
Associate Professor Kate Seib is the Associate Director (Research) and a Group Leader at the Institute for Glycomics, Griffith University Australia. Her expertise is in the field of molecular microbiology, with a focus on understanding virulence mechanisms and characterising vaccine candidates of human mucosal pathogens including Neisseria gonorrhoeae.
Dr Wilhelmina Huston
Associate Dean Teaching and Learning and Research Group Leader
University Of Technology Sydney
Viability assays for STI diagnosis
Biography
Dr Willa Huston is an Associate Professor researching the molecular microbiology of the intracellular pathogen Chlamydia. Particularly how the organism is involved in infertility and pelvic inflammatory disease in women. Her research is also focussed on improved and new strategies for treatment and diagnosis of chlamydia.
Dr Jennifer Danielewski
Research Officer
Centre for Women's Infectious Diseases, The Royal Women's Hospital, Parkville
A custom amplicon sequencing approach to detect resistance associated mutations and sequence types in Mycoplasma genitalium
Biography
Dr Jennifer Danielewski is a molecular biologist who joined the Centre for Women’s Infectious Diseases at RWH in 2007. Her research focus has been on sexually transmitted infections primarily, human papillomavirus. Recent interest in genomic applications to investigate antibiotic resistance and strain dynamics in Chlamydia trachomatis and Mycoplasma genitalium.
Dr Melinda Ashcroft
Postdoctoral Research Fellow
The Peter Doherty Institute For Infection And Immunity At The University Of Melbourne
Genomic characterisation of the Neisseria gonorrhoeae population structure in Victoria, Australia from 2017-2020
Biography
Melinda is a Postdoctoral Research Fellow and Computational Microbiologist at The University of Melbourne, with a special interest in antimicrobial resistance, mobile genetic elements and the evolution of human pathogens. Melinda research is currently focused on investigating transmission, the dynamics of populations and antimicrobial resistance of sexually transmitted bacterial infections.
Dr Gerald Murray
Research Officer
The University of Melbourne
Detection of Mycoplasma genitalium parC gene mutations associated with quinolone resistance – evaluation of a multiplex real-time PCR assay
Biography
Dr Murray is the Senior Scientist in the Centre for Women’s Infectious Diseases at the Royal Women’s Hospital/University of Melbourne. He has an interest in diseases that affect women and neonates including human papillomavirus, sexually transmitted diseases, and the analysis of the human microbiota in health and disease.
Chair
Deborah Williamson
Director
United Kingdom Health Security Agency
Speaker
Melinda Ashcroft
Postdoctoral Research Fellow
The Peter Doherty Institute For Infection And Immunity At The University Of Melbourne
Jennifer Danielewski
Research Officer
Centre for Women's Infectious Diseases, The Royal Women's Hospital, Parkville
Wilhelmina Huston
Associate Dean Teaching and Learning and Research Group Leader
University Of Technology Sydney
Gerald Murray
Research Officer
The University of Melbourne
Kate Seib
Research Leader & Deputy Director
Institute for Glycomics, Griffith University
Support Staff
Chris Buckley
Touchpoint
Linda Starke
Event Coordinator
ASHM
